Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Schwartz

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1987
A superactive insulin: [B10-aspartic acid]insulin(human)G P Schwartz, G T Burke, P G Katsoyannis
International Journal of Peptide and Protein Research|February 1, 1981
[12-asparagine-B] human insulin. An analogue with modification in the hydrophobic core of insulinG P Schwartz, G T Burke, P G Katsoyannis
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1989
A highly potent insulin: des-(B26-B30)-[AspB10,TyrB25-NH2]insulin(human)G P Schwartz, G T Burke, P G Katsoyannis
International Journal of Peptide and Protein Research|November 1, 1991
Neurophysin-neurohypophyseal hormone interactions: studies using a dansylated vasotocin analogueC A Hasselbacher, G P Schwartz, J D Glass, et al.
Biochemistry|September 13, 1983
An insulin analogue possessing higher in vitro biological activity than receptor binding affinity. [21-Proline-B]insulinG P Schwartz, G T Burke, J D Chanley, et al.
Ophthalmology|August 1, 1997
Survey of 520 eyes with uveal metastasesC L Shields, J A Shields, N E Gross, et al.
Biochemical and Biophysical Research Communications|December 31, 1990
Superactive insulinsG T Burke, S Q Hu, N Ohta, et al.
Biochemistry|August 9, 1988
Determinants of growth-promoting activity reside in the A-domain of insulin-like growth factor IZ Z Chen, G P Schwartz, L Zong, et al.
Biochemistry|March 16, 1993
Steric requirements at position B12 for high biological activity in insulinS Q Hu, G T Burke, G P Schwartz, et al.
Biochemistry|February 18, 1992
Correlation of tryptophan fluorescence intensity decay parameters with 1H NMR-determined rotamer conformations: [tryptophan2]oxytocinJ B Ross, H R Wyssbrod, R A Porter, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1987
A superactive insulin: [B10-aspartic acid]insulin(human)G P Schwartz, G T Burke, P G Katsoyannis
International Journal of Peptide and Protein Research|February 1, 1981
[12-asparagine-B] human insulin. An analogue with modification in the hydrophobic core of insulinG P Schwartz, G T Burke, P G Katsoyannis
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1989
A highly potent insulin: des-(B26-B30)-[AspB10,TyrB25-NH2]insulin(human)G P Schwartz, G T Burke, P G Katsoyannis
International Journal of Peptide and Protein Research|November 1, 1991
Neurophysin-neurohypophyseal hormone interactions: studies using a dansylated vasotocin analogueC A Hasselbacher, G P Schwartz, J D Glass, et al.
Biochemistry|September 13, 1983
An insulin analogue possessing higher in vitro biological activity than receptor binding affinity. [21-Proline-B]insulinG P Schwartz, G T Burke, J D Chanley, et al.
Ophthalmology|August 1, 1997
Survey of 520 eyes with uveal metastasesC L Shields, J A Shields, N E Gross, et al.
Biochemical and Biophysical Research Communications|December 31, 1990
Superactive insulinsG T Burke, S Q Hu, N Ohta, et al.
Biochemistry|August 9, 1988
Determinants of growth-promoting activity reside in the A-domain of insulin-like growth factor IZ Z Chen, G P Schwartz, L Zong, et al.
Biochemistry|March 16, 1993
Steric requirements at position B12 for high biological activity in insulinS Q Hu, G T Burke, G P Schwartz, et al.
Biochemistry|February 18, 1992
Correlation of tryptophan fluorescence intensity decay parameters with 1H NMR-determined rotamer conformations: [tryptophan2]oxytocinJ B Ross, H R Wyssbrod, R A Porter, et al.
Pageof 2